Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

10 results
Display

A Case of Non-Hodgkin's Lymphoma in Patient with Coombs' Negative Hemolytic Anemia and Idiopathic Thrombocytopenic Purpura

Park SY, Kim S, Kim ES, Choi SU, Hyun HJ, Ahn JY, Lee JH, Ryu SH, Park JH, Lee GI, Lee HJ

  • Cancer Res Treat.
  • 2012 Mar;44(1):69-72.
Coombs' negative autoimmune hemolytic anemia (AIHA) is a rare disease which shares similar clinical and hematological features with Coombs' positive AIHA, but its exact frequency remains unknown. There have been...
Five Cases Report of Solid Tumor Synchronously with Hematologic Malignancy

Cui Y, Liu T, Zhou Y, Ji Y, Hou Y, Jin W, Feng Y

  • Cancer Res Treat.
  • 2012 Mar;44(1):63-68.
The reported incidence of synchronous multiple primary cancer (SMPC) is rare, and it is even less common to observe synchronous solid tumor with a hematological malignancy. We report five cases...
Immunohistochemical Expression of DCUN1D1 in Non-small Cell Lung Carcinoma: Its Relation to Brain Metastasis

Yoo J, Lee SH, Lym KI, Park SY, Yang SH, Yoo CY, Jung JH, Kang SJ, Kang CS

  • Cancer Res Treat.
  • 2012 Mar;44(1):57-62.
PURPOSE: Non-small cell lung carcinoma (NSCLC) comprises 75-85% of all lung cancers, and approximately 25% of all NSCLC patients develop brain metastasis. There are no reliable markers for predicting in...
Correlation of AR, EGFR, and HER2 Expression Levels in Prostate Cancer: Immunohistochemical Analysis and Chromogenic In Situ Hybridization

Baek KH, Hong ME, Jung YY, Lee CH, Lee TJ, Park ES, Kim MK, Yoo JH, Lee SW

  • Cancer Res Treat.
  • 2012 Mar;44(1):50-56.
PURPOSE: The androgen receptor (AR) plays a central role in prostate cancer. Evidence from several groups indicates that epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2...
Weekly Gemcitabine and Docetaxel in Refractory Soft Tissue Sarcoma: A Retrospective Analysis

Lee HY, Shin SJ, Kim HS, Hong SJ, Han JW, Lim ST, Roh JK, Rha SY

  • Cancer Res Treat.
  • 2012 Mar;44(1):43-49.
PURPOSE: The combination of gemcitabine and docetaxel (GD) is used to effectively treat patients with soft tissue sarcoma (STS). It is widely considered that the conventional doses used are too...
Chemotherapy in Patients Older than or Equal to 75 Years with Advanced Non-small Cell Lung Cancer

Kim ST, Park KH, Oh SC, Seo JH, Kim JS, Kim YH, Shin SW

  • Cancer Res Treat.
  • 2012 Mar;44(1):37-42.
PURPOSE: As the number of elderly patients diagnosed with non-small cell lung carcinoma (NSCLC) increases, the number of these patients receiving chemotherapy also increases. However, limited data exists regarding the...
Prognostic Impact of Polymorphisms in the CASPASE Genes on Survival of Patients with Colorectal Cancer

Choi JY, Kim JG, Lee YJ, Chae YS, Sohn SK, Moon JH, Kang BW, Jung MK, Jeon SW, Park JS, Choi GS

  • Cancer Res Treat.
  • 2012 Mar;44(1):32-36.
PURPOSE: This study analyzed potentially functional polymorphisms in CASPASE (CASP) genes and their impact on the prognosis for Korean colorectal cancer patients. MATERIALS AND METHODS: A total of 397 consecutive patients...
Prediction of Cancer Incidence and Mortality in Korea, 2012

Jung KW, Park S, Won YJ, Kong HJ, Lee JY, Seo HG, Lee JS

  • Cancer Res Treat.
  • 2012 Mar;44(1):25-31.
PURPOSE: To estimate the current cancer burden in Korea, cancer incidence and mortality rates were projected for the year 2012. MATERIALS AND METHODS: The cancer incidence data from 1999 to 2009...
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009

Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Seo HG, Lee JS

  • Cancer Res Treat.
  • 2012 Mar;44(1):11-24.
PURPOSE: This study overviews nationwide cancer statistics, including incidence, mortality, survival, and prevalence, and their trends in Korea based on 2009 cancer incidence data. MATERIALS AND METHODS: Incidence data from 1993-2009...
Present Status and Problems on Molecular Targeted Therapy of Cancer

Saijo N

  • Cancer Res Treat.
  • 2012 Mar;44(1):1-10.
Numerous clinical trials of molecular targeted drugs for cancer have been conducted, with remarkable results for certain drugs and accumulation of "negative data" causing a hitch in the development plan...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr